Webinar – KioMedinevsone in Practice: Insights from an Orthopedic Surgeon
Osteoarthritis is a major clinical challenge, especially for active and athletic individuals. When conventional treatments like corticosteroids, hyaluronic acid, or PRP injections are no longer effective, what alternative solutions exist?
On Monday, March 24, 2025, at 7:00 PM CET, Prof. Thomas Neri will share his insights on the potential of carboxymethyl-chitosan (CM-Chitosan), a biomaterial derived from the button mushroom, in the treatment of osteoarthritis patients.
Key discussion points
🔹 Prof. Thomas Neri – Presentation of preliminary findings from the 2024 French Society of Rheumatology Congress, highlighting CM-Chitosan’s impact on osteoarthritis in active and athletic patients.
Topics covered
✔ Identifying suitable patient profiles: athletic individuals and active seniors (>50 years old) with treatment-resistant osteoarthritis.
✔ Real-world case studies and clinical protocols: how to integrate CM-Chitosan into a broader treatment approach?
Practical Information
📅 Date: Monday, March 24, 2025
⏰ Time: 7:00 PM – 7:30 PM CET
💻 Format: Live webinar with interactive Q&A
📌 Register now! 👉 https://app.livestorm.co/kiomed-pharma/kiomedine-webinar-en-2403?s=5c7fc69c-8163-4572-8b11-ae41fa9f5f45
Who Should Attend?
Sports medicine physicians, orthopedic surgeons, rheumatologists, physiotherapists, and rehabilitation specialists looking for innovative approaches to osteoarthritis management.
💡 Why Join?
This webinar provides a unique opportunity to explore the potential of CM-Chitosan as an innovative treatment for active and athletic osteoarthritis patients.
📩 For inquiries, contact Fabrice Letimier at fabrice.letimier@kiomedpharma.com
